Citations for
1TNFRSF9, TNFSF9
The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.
Barao I.
Front Immunol 3:402. doi: 10.3389/fimmu.2012.00402. eCollection 2012. 2013
2PRDM1, TNFSF9
PRDM1 is a tumor suppressor gene in natural killer cell malignancies.
Küçük C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G, Au WY, McKeithan TW, Chan WC.
Proc Natl Acad Sci U S A 108(50):20119-24. Epub 2011 Dec 5. 2011
3CD27, CD70, TNFRSF25, TNFRSF4, TNFRSF9, TNFSF15, TNFSF4, TNFSF9
The role of TNF superfamily members in T-cell function and diseases.
Croft M.
Nat Rev Immunol 9(4):271-85. Review. 2009
4TNFSF9
CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response.
Lippert U, Zachmann K, Ferrari DM, Schwarz H, Brunner E, Mahbub-Ul Latif AH, Neumann C, Soruri A.
Eur J Immunol 38(4):1024-32. Erratum in: Eur J Immunol. 2008 Jun;38(6):1767. PMID: 18395851 2008
5TNFSF9
Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M, Phan TT, Searle PF.
Int Immunol 19(12):1383-94. Epub 2007 Oct 31. 2007
6TNFSF9
Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival.
Ek S, Björck E, Högerkorp CM, Nordenskjöld M, Porwit-MacDonald A, Borrebaeck CA.
Int J Cancer 118(8):2092-7. 2006
7TNFSF9
Expression of CD137 and CD137 ligand in colorectal cancer patients.
Dimberg J, Hugander A, Wågsäter D.
Oncol Rep 15(5):1197-200. 2006
8TNFSF9
Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis.
Liu GZ, Gomes AC, Putheti P, Karrenbauer V, Kostulas K, Press R, Hillert J, Hjelmström P, Gao XG.
Scand J Immunol 64(4):412-9. 2006
9TNFSF9
Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis.
Jung HW, Choi SW, Choi JI, Kwon BS.
Exp Mol Med 36(1):13-22. 2004
10TNFSF9
Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2.
Reali C, Curto M, Sogos V, Scintu F, Pauly S, Schwarz H, Gremo F.
J Neurosci Res 74(1):67-73. 2003
11TNFSF9
4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T, Bukczynski J, Watts TH.
J Immunol 168(10):4897-906. 2002
12TNFSF9
4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells.
Kim YJ, Li G, Broxmeyer HE.
J Hematother Stem Cell Res 11(6):895-903. 2002
13TNFSF9
Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.
Salih HR, Schmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, Nuessler V, Kiener PA.
J Immunol 167(7):4059-66. 2001
14TNFSF9
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells.
Salih HR, Kosowski SG, Haluska VF, Starling GC, Loo DT, Lee F, Aruffo AA, Trail PA, Kiener PA.
J Immunol 165(5):2903-10. 2000
15TNFSF9, TNFRSF9
Molecular cloning of a ligand for the inducible T cell gene 4-1BB : a member of an emerging family of cytokines with homology to tumor necrosis factor.
Goodwin RG, et al.
Eur J Immunol 23 : 2631-2641. 1993